Recombinant Proteins
- (2)
- (2)
- (1)
- (2,981)
- (1)
- (23,536)
- (5)
- (1)
- (1)
- (68)
- (542)
- (9,493)
- (23)
- (1)
- (7)
- (2)
- (13)
- (5)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (256)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (1)
- (253)
- (3)
- (26,512)
- (1)
- (1)
- (2)
- (1)
- (32)
- (1)
- (37,971)
- (1,337)
- (2)
- (2)
- (8)
- (43)
- (3)
- (806)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (140)
- (4)
- (1)
- (110)
- (4,345)
- (3)
- (4)
- (6)
- (7)
- (5)
- (1)
- (1,469)
- (1)
- (1)
- (1)
- (14)
- (11,449)
- (50)
- (6)
- (8)
- (31)
- (21)
- (1)
- (45)
- (4)
- (110)
- (1)
- (34)
- (2)
- (3)
- (129)
- (4)
- (148)
- (98)
- (3)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,575)
- (2)
- (1)
- (160)
- (48)
- (2,559)
- (3)
- (1)
- (2)
- (9)
- (27)
- (1)
- (2)
- (21,948)
- (2,939)
- (4)
- (1)
- (2)
- (114)
- (2,860)
- (4)
- (4)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (34,932)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (6)
- (1)
- (1)
- (18,063)
- (6)
- (162)
- (4)
- (1)
- (14)
- (3)
- (1)
- (3)
- (2)
- (17)
- (19)
- (1)
- (3)
- (3)
- (4)
- (39,205)
- (1,835)
- (1)
- (3)
- (296)
- (9)
- (77,247)
- (1)
- (15)
- (1)
- (2)
- (52,352)
- (14,103)
- (245)
- (168)
- (77)
- (3,358)
- (2)
- (1)
- (2)
- (1)
- (90)
- (557)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (29)
- (2)
- (5)
- (9)
- (15)
- (1)
- (29)
- (72)
- (8)
- (27)
- (1)
- (1,377)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (6)
- (7)
- (1)
- (1)
- (38,027)
- (24)
- (22)
- (8)
- (5)
- (2,390)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (45)
- (32)
- (24)
- (1)
- (2)
- (23)
- (445)
- (8)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (42)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,571)
- (1)
- (44)
- (1)
- (3)
- (79)
- (65,627)
Filtered Search Results
R&D Systems™ Recombinant Human IL-17A/F Heterodimer Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | IL-17A: 15.7 kDa and IL-17F: 15 kDa |
| Quantity | 25 μg |
| Structural Form | Disulfide-linked heterodimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived human IL-17A/F Heterodimer protein, (N-terminus) Met Human IL-17A (Ile20-Ala155) Accession &Num; Q16552 Met Human IL-17F (Arg31-Gln163) Accession &Num; Q96PD4 (C-terminus) |
| Recombinant | Recombinant |
| Name | IL-17A/F Heterodimer |
R&D Systems™ Recombinant Human IL-36Ra/IL-1F5 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 17 kDa |
| Gene ID (Entrez) | 26525 |
| Quantity | 25 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived human IL-36Ra/IL-1F5 protein Val2-Asp155 |
| Recombinant | Recombinant |
| Name | IL-36Ra/IL-1F5 |
R&D Systems™ Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 26 kDa, reducing conditions; M.W. (theoretical): 21.7 kDa |
| Gene Symbol | TNFSF13 |
| Quantity | 10 μg |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | APRIL/TNFSF13 |
| Source | Human embryonic kidney cell, HEK293-derived human APRIL/TNFSF13 protein HA (YPYDVPDYA) GCN4-IZ GGGSGGGSGGGS Human April (Ala105-Leu250) (N-terminus) Accession # O75888 (C-terminus) |
| Name | APRIL/TNFSF13 |
| Accession Number | O75888 |
| Gene ID (Entrez) | 8741 |
| Structural Form | Noncovalently-linked homotrimer |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human IL-17F (NS0-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human BAFF/BLyS/TNFSF13B (CHO-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 17.0 kDa (monomer) |
| Gene ID (Entrez) | 10673 |
| Quantity | 25 μg |
| Structural Form | High Molecular Weight Multimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Chinese Hamster Ovary cell line,CHO-derived human BAFF/BLyS/TNFSF13B protein Ala134-Leu285 |
| Recombinant | Recombinant |
| Name | BAFF/BLyS/TNFSF13B |
R&D Systems™ Recombinant Human LAG-3 His-tag Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human IL-34 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 26.1 kDa |
| Gene ID (Entrez) | 146433 |
| Quantity | 10 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Mouse myeloma cell line,NS0-derived human IL-34 protein Asn21-Pro242,with a C-terminal 6-His tag |
| Recombinant | Recombinant |
| Name | IL-34 |
R&D Systems™ Recombinant Human FCAR/CD89 Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
BD Recombinant Human Interleukin-1β (IL-1β)
Determined by SDS-PAGE analysis, and an absorbance assay based on the Beers-Lambert law
Invitrogen™ Lycopersicon Esculentum (Tomato) Lectin (LEL, TL), DyLight 649
Used as marker of blood vessels and microglial cells in rodents and in neuroscience research
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
R&D Systems™ Recombinant Human B7-2/CD86 His Tag Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Mouse IgG2a Lambda Isotype Control (M2AL), R&D Systems™
A Novus product, part of R&D Systems. Mouse Monoclonal Antibody
R&D Systems™ Recombinant Human Endoglin/CD105 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 61 kDa |
| Gene ID (Entrez) | 2022 |
| Quantity | 25 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Mouse myeloma cell line,NS0-derived human Endoglin/CD105 protein Glu26-Gly586 |
| Recombinant | Recombinant |
| Name | Endoglin/CD105 |